InvestorsHub Logo
Followers 8
Posts 2755
Boards Moderated 0
Alias Born 08/20/2009

Re: amank7 post# 759

Thursday, 03/03/2011 1:29:28 PM

Thursday, March 03, 2011 1:29:28 PM

Post# of 39185
ITNS(0.012)Reverse Merger Mind Blowing DD finds >>>

ITNS >>PENNIES TO DOLLARS PLAY >>mind blowing DD



Itonis Inc is a shell company in the process of reverse merger.

first they filed a 15-12g

http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=7675298

and then a Nevada SOS with new CEO

nvsos.gov/sosentitysearch/CorpDetails.aspx



Share Structure :

Authorized- 300 Million

Outstanding- 124,930,223

Float- 13,800,000


from the NEVADA SOS filing we have a new CEO on board:

Director - HENNING MOELGAARD

from HERNING a city in Danemark


who is HENNING MOELGAARD the new CEO >?

HENNING MOELGAARD is a well known Cardiologist in Denmark

and dr Henning Mølgaard has a Pacemaker Treatment for Recurrent Vasovagal Syncope (bradycardia)



he already finished the clinical trials back in 2006 !!!


http://clinicaltrials.gov/ct2/show/NCT00292825



Pacemakers Prevent One Form of Fainting - Vasovagal Syncope(bradycardia)

The vasovagal syncope is one of the more common and potentially serious causes of fainting. The condition develops when an inappropriate reflex in the nervous system leads to opening (dilation) of the blood vessels along with slowing of the heart rate (bradycardia).

The North American Vasovagal Pacemaker Study shows clearly that patients with severe symptoms from vasovagal syncope can significantly reduce (85% reduction in the study) their chances for recurrent episodes by receiving a heart pacemaker


http://www.medicinenet.com/script/main/art.asp?articlekey=8089


a recent study on Henning Mølgaard, MD Pacemaker at Skejby on (bradycardia) Pacemaker dated july 2010

http://www.bioportfolio.com/resources/trial/109347/Effect-Of-Closed-Loop-Pacemaker-Treatment-On-Recurrent-Vasovagal-Syncope.html



Now the main Question is ?

which company is selling this pacemaker today ???

from dr Henning Mølgaard clinical trials in 2006 we can see that Biotronik SE & Co. KG was the Collaborator on those pacemaker Clinical trials


link:

http://clinicaltrials.gov/ct2/show/NCT00292825


and the pacemaker is now selling though Biotronik


BIOTRONIK® is a leading European company in the field of biomedical technology. We focus on devices for vascular intervention and electrotherapy of the heart.

the PACEMAKER can be seen on under this link:

http://www.biotronik.de/en/de/2768


the PACEMAKER has received FDA approval last year !!!

BIOTRONIK Evia Advanced Pacemaker Receives FDA Approval in may 2010

BIOTRONIK announced that the U.S. Food and Drug Administration has cleared the Evia® pacemaker for distribution in the U.S., giving physicians and patients access to a unique Bradycardia system designed and manufactured with BIOTRONIK's unparalleled legacy of quality.


link:

http://www.medicalnewstoday.com/articles/188664.php



BIOTRONIK is a PRIVATE Co today

http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=6500053


BIOTRONIK direct competitor in the US market for (bradycardia)pacemakers is MEDTRONIC trading on NYSE under the symbol (MDT) at 40 $ with 43 B market cap!!!

conclusion:

the BIOTRONIK pacemaker collaborator from 2006 clinical trials
is dr Henning Mølgaard and the bradycardia pacemaker is selling through BIOTRONIK is a PRIVATE Co and recently dr Henning Mølgaard became CEO of the public shell ITNS.pk!!!

IL LOOKS LIKE BIOTRONIK has finally decided to enter the US market as a public company after last year FDA approval of its Pacemaker device

this is a NO BRAINER PLAY !!!!

all the stars are lining for BIOTRONIK to be the MERGER candidat
in ITNS

ITNS traded as high as 0.07 last friday as you can see on Barchart ,the volume has been picking up lately on it and the accumulation is heavy

http://www.barchart.com/detailedquote/stocks/ITNS

the stock is rated strong BUY

this could be a pennies to dollars play

watch for big action on the stock

Balamidas